Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Hematology & Oncology|January 7, 2018
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemiaAmy Y Wang, Howard Weiner, Margaret Green, et al.JCI Insight|August 23, 2022
Multiparametric MRI to quantify disease and treatment response in mice with myeloproliferative neoplasmsTanner H Robison, Manisha Solipuram, Kevin Heist, et al.The New England Journal of Medicine|February 21, 2024
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia VeraMarina Kremyanskaya, Andrew T Kuykendall, Naveen Pemmaraju, et al.International Journal of Hematology|October 26, 2023
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemiaLauren T Shinn, Lydia L Benitez, Anthony J Perissinotti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, et al.The Lancet. Oncology|October 3, 2024
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trialEunice S Wang, Ghayas C Issa, Harry P Erba, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2025
Ziftomenib in Relapsed or Refractory NPM1-Mutated AMLEunice S Wang, Pau Montesinos, James Foran, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2026
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026Daniel A Pollyea, Jessica K Altman, Rita Assi, et al.Pageof 4